Drugs & medicalClass I

FA Online Inc recalls ForeverMen Natural Energy Boost Capsules, packaged in a box containing a 10-count blister card.

Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this unapproved drug.

Read the official notice →
Date
2024-05-01
Country
United States
Brand
FA Online Inc
Product
ForeverMen Natural Energy Boost Capsules, packaged in a box containing a 10-count blister card.
Classification
Class I
Units
USA Nationwide. The product was sold via Amazon Market Place.
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in the United States

  1. 2024-05-01
  2. US
    Drugs & medicalClass II

    EPI Health, LLC recalls minolira (minocycline hydrochloride) extended-release tablets, 135mg 30-count Bottle, Rx Only, Mfg by: Dr Reddy's Laboratories Limited,…

    CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

    FDA · DrugEPI Health, LLCUS NationwideOfficial notice →
  3. US
    Drugs & medicalClass II

    Glenmark Pharmaceuticals Inc., USA recalls Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only,…

    Failed Dissolution Specifications

    FDA · DrugGlenmark Pharmaceuticals Inc., USANationwide in the USA.Official notice →
  4. US
    Drugs & medicalClass II

    Cipla USA, Inc. recalls Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton containing 30…

    Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.

    FDA · DrugCipla USA, Inc.USA nationwide.Official notice →
  5. US
    Drugs & medicalClass III

    Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. recalls Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America…

    Cross Contamination with Other Products

    FDA · DrugSecond Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.USA nationwide.Official notice →
  6. US
    Drugs & medicalClass II

    Nomax Inc recalls GloStrips, Fluorescein Sodium Ophthalmic Strips USP (0.6 mg Fluorescein), Rx Only, a) 100 strips per carton, NDC 51801-003-40; b) 300…

    Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.

    FDA · DrugNomax IncNationwide in the USAOfficial notice →
  7. US
See all drugs & medical recalls →